Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center

This prospective single-center study examined associations between serum cytokines—TNF-α, IL-2, and IL-10—and outcomes in stage IV non-small cell lung cancer (NSCLC, <i>n</i> = 43) and melanoma (<i>n</i> = 15) patients treated with Nivolumab at the Oncology Institute in Cluj-Napoca, Romania. Cytokin...

Descrición completa

Detalles Bibliográficos

Principais autores:	Alina Miruna Grecea-Balaj, Olga Soritau, Ioana Brie, Maria Perde-Schrepler, Piroska Virag, Eva Fischer-Fodor, Nicolae Todor, Mihai Cenariu, Ioana Nedelea, Tudor Eliade Ciuleanu
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-09-01
Series:	Current Issues in Molecular Biology
Assuntos:	immune checkpoint inhibitor NSCLC melanoma cytokines Il-2 IL-10
Acceso en liña:	https://www.mdpi.com/1467-3045/47/9/746
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!